Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 9Completed 4Withdrawn 3Terminated 1Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 51Lung Neoplasms 40Carcinoma, Non-Small-Cell Lung 28Neoplasm Metastasis 25Brain Neoplasms 23Lymphoma, Large B-Cell, Diffuse 22Pancreatic Neoplasms 21Breast Neoplasms 20Glioma 19Squamous Cell Carcinoma of Head and Neck 18Glioblastoma 17Multiple Myeloma 16Urinary Bladder Neoplasms 13Colorectal Neoplasms 13Carcinoma, Renal Cell 13Mouth Neoplasms 12Oropharyngeal Neoplasms 11Lymphoma, Mantle-Cell 11Carcinoma 11Triple Negative Breast Neoplasms 10Melanoma 10Leukemia, Lymphocytic, Chronic, B-Cell 10Laryngeal Neoplasms 10Ovarian Neoplasms 9Nasopharyngeal Carcinoma 8Lymphoma, Follicular 8Leukemia, Myeloid, Acute 8Hypopharyngeal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, B-Cell 7

Interventions

Cyclophosphamide 6Temozolomide 5Etoposide 5Vincristine 3Radiotherapy 3Cisplatin 3lutetium Lu 177 dotatate 2etoposide phosphate 2Radiation 2Filgrastim 2Celecoxib 2Carboplatin 2sodium thiosulfate 1ribociclib 1pegfilgrastim 1palbociclib 1olaparib 1ibrutinib 1fludarabine 1fenofibric acid 1abemaciclib 1Topotecan 1Thiotepa 1Thalidomide 1Tamoxifen 1Tablets 1Standard of Care 1Specimen Handling 1Platinum 1ONC206 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Medulloblastoma × Magnetic Resonance Spectroscopy × Clear all
NCT05382338 2026-05-05

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Children's Oncology Group

Phase 3 Recruiting
225 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡